I'm giving a talk today on "The Law and Economics of the Parable of the Talents" at the University Catholic Center at UCLA Faculty/Staff Winter Quarter Gathering.
My talk on the Parable of the Talents is based on my chapter in Research Handbook on Fiduciary Law 97 (Edward Elgar Publishing; D. Gordon Smith & Andrew S. Gold eds. 2018) https://t.co/9JsW3985vn
I recorded a video of myself presenting this talk, which I posted to YouTube: A Law and Economics Analysis of the Parable of the Talents https://t.co/0ylI7cRmfb
A management buyout (MBO) occurs when a public company's management team purchases the company from its shareholders. The substance of the transaction typically is a leveraged buyout. The form can be either a merger between the company and an acquisition corporate shell set up by the management group or a two-step acquisition in which management first makes a tender offer and then freezes out any remaining shareholders with a merger. Management often will seek a private equity fund to serve as a financial partner.
The transaction can produce significant gains, but it also poses a serious conflict of interest. Managers are simultaneously acting as agents of the shareholders and as buyers. In effect, they are on both sides of the deal. In addition, because management typically will have private information, some regard MBOs as simply a very large insider trading transaction.
This video explains how MBOs work and provides an overview of judicial review.
In April 2022, Elon Musk bought a ~9% stake in Twitter. In response, Twitter's board adopted a shareholder rights plan--more commonly known as a poison pill. In this video, I explain what a poison pill, how it works, and why companies use them. If you want even more information about the poison pill, my book Mergers and Acquisitions has an extended treatment. https://amzn.to/38Pkj06